188 related articles for article (PubMed ID: 29379789)
1. Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.
Sena BF; Figueiredo JL; Aikawa E
Front Cardiovasc Med; 2017; 4():88. PubMed ID: 29379789
[TBL] [Abstract][Full Text] [Related]
2. Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study.
Petanceska S; Burke S; Watson SJ; Devi L
Neuroscience; 1994 Apr; 59(3):729-38. PubMed ID: 8008216
[TBL] [Abstract][Full Text] [Related]
3. The cathepsin family and their role in colorectal cancer.
Kuester D; Lippert H; Roessner A; Krueger S
Pathol Res Pract; 2008; 204(7):491-500. PubMed ID: 18573619
[TBL] [Abstract][Full Text] [Related]
4. The role of thiol proteases in tissue injury and remodeling.
Chapman HA; Munger JS; Shi GP
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S155-9. PubMed ID: 7952652
[TBL] [Abstract][Full Text] [Related]
5. Differential Cleaving of Specific Substrates for Cathepsin-Like Activity Shows Cysteine and Serine Protease Activities and a Differential Profile Between
Torralbo-Ramírez V; Molina-Fernández D; Malagón D; Benítez R; Adroher FJ
Foodborne Pathog Dis; 2019 Nov; 16(11):744-751. PubMed ID: 31215796
[TBL] [Abstract][Full Text] [Related]
6. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
7. The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.
Cocchiaro P; De Pasquale V; Della Morte R; Tafuri S; Avallone L; Pizard A; Moles A; Pavone LM
Front Cell Dev Biol; 2017; 5():114. PubMed ID: 29312937
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin cysteine proteases in cardiovascular disease.
Lutgens SP; Cleutjens KB; Daemen MJ; Heeneman S
FASEB J; 2007 Oct; 21(12):3029-41. PubMed ID: 17522380
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655
[TBL] [Abstract][Full Text] [Related]
11. Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.
Wu H; Du Q; Dai Q; Ge J; Cheng X
J Atheroscler Thromb; 2018 Feb; 25(2):111-123. PubMed ID: 28978867
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal digestion of thyroglobulin: role of cathepsin D and thiol proteases.
Yoshinari M; Taurog A
Endocrinology; 1985 Oct; 117(4):1621-31. PubMed ID: 3896765
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
14. Human cathepsins F and W: A new subgroup of cathepsins.
Wex T; Levy B; Wex H; Brömme D
Biochem Biophys Res Commun; 1999 Jun; 259(2):401-7. PubMed ID: 10362521
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
16. Proteases involved in the metabolic degradation of human interleukin-1beta by rat kidney lysosomes.
Kudo S; Miyamoto G; Kawano K
J Interferon Cytokine Res; 1999 Apr; 19(4):361-7. PubMed ID: 10334387
[TBL] [Abstract][Full Text] [Related]
17. Cathepsins mediate tumor metastasis.
Tan GJ; Peng ZK; Lu JP; Tang FQ
World J Biol Chem; 2013 Nov; 4(4):91-101. PubMed ID: 24340132
[TBL] [Abstract][Full Text] [Related]
18. Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes.
Linnevers C; Smeekens SP; Brömme D
FEBS Lett; 1997 Apr; 405(3):253-9. PubMed ID: 9108299
[TBL] [Abstract][Full Text] [Related]
19. Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.
Schwenck J; Maurer A; Fehrenbacher B; Mehling R; Knopf P; Mucha N; Haupt D; Fuchs K; Griessinger CM; Bukala D; Holstein J; Schaller M; Menendez IG; Ghoreschi K; Quintanilla-Martinez L; Gütschow M; Laufer S; Reinheckel T; Röcken M; Kalbacher H; Pichler BJ; Kneilling M
Theranostics; 2019; 9(13):3903-3917. PubMed ID: 31281521
[TBL] [Abstract][Full Text] [Related]
20. Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor.
Ahmad S; Siddiqi MI
J Mol Model; 2017 Mar; 23(3):92. PubMed ID: 28236030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
